The upregulation of hsa-mir-181b-1 and downregulation of its target CYLD in the late-stage of tumor progression of breast cancer - Andalib, A; Rashed, S; Dehbashi, M; Hajati, J; Noorbakhsh, F; Ganjalikhani-Hakemi, M (Indian Journal of Clinical Biochemistry, 2020)